IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

J. Goldman & Co LP

Q2 2019 Holdings

Filed 2019-08-14 | 257 holdings | $50.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Axsome Therapeutics Inc(AXSM)COM05464T104$249.0K9,6780.5%
Collegium Pharmaceutical Inc(COLL)COM19459J104$460.0K34,9990.9%
Daktronics Inc(DAKT)COM234264109$1.2M194,8702.4%
DXC Technology Co(DXC)COM23355L106$2.4M43,8754.8%
Boston Scientific Corp(BSX)COM101137107$6.5M151,64213.0%
Conmed Corp(CNMD)COM207410101$13.9M162,77127.8%
BJS Whsl Club Hldgs Inc(BJ)COM05550J101$23.7M899,55847.4%
PreviousPage 6 of 6